Bionomics Future Growth
Future criteria checks 2/6
Bionomics's earnings are forecast to decline at 44.8% per annum while its annual revenue is expected to grow at 70.1% per year. EPS is expected to decline by 37.2% per annum.
Key information
-44.8%
Earnings growth rate
-37.2%
EPS growth rate
Biotechs earnings growth | 24.8% |
Revenue growth rate | 70.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 26 Mar 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 5 | -60 | N/A | N/A | 2 |
6/30/2024 | 5 | -39 | N/A | N/A | 2 |
12/31/2023 | 1 | -31 | -27 | -27 | N/A |
9/30/2023 | 1 | -31 | -24 | -24 | N/A |
6/30/2023 | 1 | -32 | -21 | -21 | N/A |
3/31/2023 | 3 | -28 | -20 | -20 | N/A |
12/31/2022 | 6 | -25 | -18 | -18 | N/A |
9/30/2022 | 6 | -23 | -20 | -20 | N/A |
6/30/2022 | 6 | -22 | -22 | -22 | N/A |
3/31/2022 | 3 | -22 | -20 | -20 | N/A |
12/31/2021 | 0 | -22 | -19 | -19 | N/A |
9/30/2021 | 1 | -15 | -13 | -13 | N/A |
6/30/2021 | 1 | -9 | -8 | -8 | N/A |
3/31/2021 | 1 | -4 | N/A | N/A | N/A |
12/31/2020 | 2 | 1 | -5 | -5 | N/A |
9/30/2020 | 2 | -3 | -5 | -4 | N/A |
6/30/2020 | 3 | -6 | -4 | -4 | N/A |
12/31/2019 | 6 | -5 | -9 | -9 | N/A |
9/30/2019 | 7 | -8 | -13 | -12 | N/A |
6/30/2019 | 7 | -10 | -16 | -16 | N/A |
3/31/2019 | 8 | -20 | -15 | -15 | N/A |
12/31/2018 | 8 | -28 | -15 | -14 | N/A |
9/30/2018 | 10 | -27 | -18 | -17 | N/A |
6/30/2018 | 12 | -25 | -21 | -20 | N/A |
3/31/2018 | 19 | -15 | -16 | -16 | N/A |
12/31/2017 | 27 | -6 | -11 | -11 | N/A |
9/30/2017 | 27 | -6 | N/A | -6 | N/A |
6/30/2017 | 27 | -7 | N/A | -1 | N/A |
3/31/2017 | 22 | -12 | N/A | -7 | N/A |
12/31/2016 | 16 | -17 | N/A | -13 | N/A |
9/30/2016 | 18 | -17 | N/A | -14 | N/A |
6/30/2016 | 19 | -17 | N/A | -15 | N/A |
3/31/2016 | 19 | -19 | N/A | -17 | N/A |
12/31/2015 | 18 | -21 | N/A | -18 | N/A |
9/30/2015 | 17 | -19 | N/A | -6 | N/A |
6/30/2015 | 15 | -17 | N/A | 5 | N/A |
3/31/2015 | 22 | -6 | N/A | 6 | N/A |
12/31/2014 | 29 | 4 | N/A | 7 | N/A |
9/30/2014 | 28 | 4 | N/A | -3 | N/A |
6/30/2014 | 27 | 3 | N/A | -13 | N/A |
3/31/2014 | 19 | -5 | N/A | -9 | N/A |
12/31/2013 | 12 | -13 | N/A | -5 | N/A |
9/30/2013 | 12 | -11 | N/A | -8 | N/A |
6/30/2013 | 12 | -10 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BNOX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BNOX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BNOX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BNOX's revenue (70.1% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: BNOX's revenue (70.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BNOX's Return on Equity is forecast to be high in 3 years time